![Xin Sun](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Xin Sun
Direktor/Vorstandsmitglied bei
EVEREST MEDICINES LIMITED
Profil
Xin Sun is currently Chairman-Supervisory Board at Scivita Medical Technology Co., Ltd. since 2021.
Mr. Sun is Non-Executive Director at MicroPort Cardiac Rhythm Management International Ltd. since 2023, Everest Medicines Ltd. since 2025, and NeuroGen Pharma Ltd. since 2026.
Mr. Sun is Managing Director at CBC Group Co., Ltd. and Hillhouse Capital Management Co Ltd since 2017.
Mr. Sun is also a Research Associate at Genentech, Inc. Former roles include Non-Executive Director at Luye Pharma Group Ltd. from 2021 to 2023, Non-Executive Director at Shanghai MicroPort MedBot (Group) Co., Ltd. from 2021 to 2023, and Vice President at Affinity Equity Partners (HK) Ltd. Education includes undergraduate degrees from Peking University in 2003 and The Trustees of Columbia University in The City of New York in 2013, a graduate degree from Duke University in 2006, and an MBA from Columbia Business School.
Aktive Positionen von Xin Sun
| Unternehmen | Position | Beginn |
|---|---|---|
| EVEREST MEDICINES LIMITED | Direktor/Vorstandsmitglied | 11.12.2025 |
Scivita Medical Technology Co., Ltd.
 Scivita Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Operates a medical device company that develops, manufactures medical endoscopes and related products | Vorsitzender | 22.06.2021 |
MicroPort Cardiac Rhythm Management International Ltd.
 MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Direktor/Vorstandsmitglied | 17.07.2020 |
CBC Group Co., Ltd. | Corporate Officer/Principal | - |
Hillhouse Capital Management Co Ltd
 Hillhouse Capital Management Co Ltd Investment Trusts/Mutual FundsMiscellaneous Operates as a fund | Corporate Officer/Principal | 01.01.2017 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Xin Sun
| Unternehmen | Position | Ende |
|---|---|---|
| SHANGHAI MICROPORT MEDBOT (GROUP) CO., LTD. | Direktor/Vorstandsmitglied | 29.12.2023 |
| LUYE PHARMA GROUP LTD. | Direktor/Vorstandsmitglied | 06.12.2023 |
Affinity Equity Partners (HK) Ltd.
 Affinity Equity Partners (HK) Ltd. Investment ManagersFinance Affinity Equity Partners invests in the companies located in Australia, Greater China, Hong Kong, Japan, Korea, Taiwan, and Singapore. The firm targets companies operating in the fields of consumer, retail, food & beverage, healthcare services, entertainment & media, financial services, software, business services and acquires minority investments. | Corporate Officer/Principal | - |
Ausbildung von Xin Sun
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
96
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Peking University
 Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Affinity Equity Partners (HK) Ltd.
Affinity Equity Partners (HK) Ltd. Investment ManagersFinance Affinity Equity Partners invests in the companies located in Australia, Greater China, Hong Kong, Japan, Korea, Taiwan, and Singapore. The firm targets companies operating in the fields of consumer, retail, food & beverage, healthcare services, entertainment & media, financial services, software, business services and acquires minority investments. | Finance |
Luye Pharma Group Ltd.
 Luye Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Everest Medicines Ltd.
 Everest Medicines Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapies to address critical unmet medical needs | Health Technology |
CBC Group Co., Ltd. | |
Scivita Medical Technology Co., Ltd.
Scivita Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Operates a medical device company that develops, manufactures medical endoscopes and related products | Health Technology |
Shanghai MicroPort MedBot (Group) Co., Ltd.
 Shanghai MicroPort MedBot (Group) Co., Ltd. Medical SpecialtiesHealth Technology Manufactures surgical robotic systems and medical instruments | Health Technology |
Hillhouse Capital Management Co Ltd
Hillhouse Capital Management Co Ltd Investment Trusts/Mutual FundsMiscellaneous Operates as a fund | Miscellaneous |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
